The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LI.ak

Cardiotoxicity

Publications

Kota V, Clemmons A, Chand A, Simmons J, Mansour J, Kolhe R, Jillella A

Congestive heart failure during induction with anthracycline-based therapy in patients with acute promyelocytic leukemia.

The Journal of community and supportive oncology 2014 Nov;12;390-3 — 2014 Nov — 390-3

Anderlini P, Benjamin RS, Wong FC, Kantarjian HM, Andreeff M, Kornblau SM, O'Brien S, Mackay B, Ewer MS, Pierce SA

Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995 Nov;13;2827-34 — 1995 Nov — 2827-34